《大行報告》瑞信上調瑞聲(02018.HK)目標價至63.1元 評級「跑贏大市」
瑞信發表報告,預期瑞聲科技(02018.HK)今年第二季業績將遜市場預期,主要由於毛利率料僅25.4%,低於市場預期的29.1%。至於純利估計按年增長27%至3.41億元人民幣,但仍較市場預期低26%。次季業績遜或帶來短期股價壓力,但料亦提供良好介入機會。
該行又預料,在iOS/Android智能手機補貨及光學業務出貨提升下,集團下半年的盈利能力會有改善,預期光學業務將繼續是集團的主要增長動力,貢獻明年及2023年增加收入的73%及67%。
瑞信上調瑞聲股份目標價,由48.5元升至63.1元,評級維持「跑贏大市」,但調低集團今年每股盈利預測6%,以反映第二季產能利用率較預期差。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.